Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Akebia Therapeutics (AKBA) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Akebia Therapeutics (AKBA) over the last 10 years, with Q3 2025 value amounting to $540000.0.

  • Akebia Therapeutics' Profit After Tax rose 10269.47% to $540000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.9 million, marking a year-over-year increase of 6541.79%. This contributed to the annual value of -$69.4 million for FY2024, which is 3367.36% down from last year.
  • Latest data reveals that Akebia Therapeutics reported Profit After Tax of $540000.0 as of Q3 2025, which was up 10269.47% from $247000.0 recorded in Q2 2025.
  • In the past 5 years, Akebia Therapeutics' Profit After Tax registered a high of $29.4 million during Q2 2022, and its lowest value of -$83.0 million during Q2 2021.
  • Over the past 5 years, Akebia Therapeutics' median Profit After Tax value was -$18.0 million (recorded in 2024), while the average stood at -$25.8 million.
  • Per our database at Business Quant, Akebia Therapeutics' Profit After Tax skyrocketed by 13546.45% in 2022 and then crashed by 381400.65% in 2024.
  • Quarter analysis of 5 years shows Akebia Therapeutics' Profit After Tax stood at -$69.9 million in 2021, then surged by 91.31% to -$6.1 million in 2022, then skyrocketed by 110.11% to $614000.0 in 2023, then tumbled by 3814.01% to -$22.8 million in 2024, then soared by 102.37% to $540000.0 in 2025.
  • Its Profit After Tax stands at $540000.0 for Q3 2025, versus $247000.0 for Q2 2025 and $6.1 million for Q1 2025.